The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of See Tai Sandi since 2025.
This trader's CIK number is 2009350.
At the time of last reporting, See Tai Sandi was the Chief Development Officer of Lexeo Therapeutics, Inc.. (stock ticker symbol LXEO).
Also see all insider trading activities at Lexeo Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | LXEO | 0 | $0 | 2,235 | $9,358 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-18 | LXEO | Sale | 382 | 4.67 | 1,783 |
| 2025-05-16 | LXEO | Sale | 367 | 2.77 | 1,018 |
| 2025-02-19 | LXEO | Sale | 1,486 | 4.41 | 6,557 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by See Tai Sandi (Chief Development Officer of Lexeo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.